aTyr Pharma News and Activities
Presence
aTyr Pharma develops medicines for immune and lung diseases. Its main products are biologic drug candidates and research services for patients, healthcare providers, and clinical partners.
aTyr Pharma products and services overview:
- Biologic medicines
- Immune therapies
- Lung disease treatments
- Clinical development
- Drug research
Revenue: ~$7 million
Employees: 85
Headquarters: San Diego, United States (USA)
aTyr Pharma is one of the...
aTyr Pharma is a company listed under the stock ticker ATYR (US).
Executives
View the org chart displaying its 22 main executives
Most searched biographies at aTyr Pharma
- Sanjay Shukla, President, Chief Executive Officer and Director
- Timothy Coughlin, Chairman of the Board
- Sara Zaknoen, Director
Create your alert
to follow the executive moves at aTyr Pharma.
Pharmaceuticals
aTyr Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by aTyr Pharma
- aTyr Pharma to Present at Life Sciences Investor Forum on September 17th
- aTyr Pharma to Participate in October Virtual Investor Events | aTyr Pharma
- aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan | aTyr Pharma
- aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC | aTyr Pharma
- aTyr Pharma to Present at September Investor Conferences | aTyr Pharma
- aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs | aTyr Pharma
- aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan | aTyr Pharma
- aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results | aTyr Pharma
- aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting II | aTyr Pharma
- aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection | aTyr Pharma
- View more press releases Close
Social media about aTyr Pharma
- aTyr Pharma on Wikipedia, Google News & Yahoo Finance
- aTyr Pharma on LinkedIn, X (Twitter) & YouTube
